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Abstract
Self-management (SM) is defined as the provision of interventions to increase patients’ skills and confidence,
empowering the individual to take an active part in their disease management. There is uncertainty regarding
the optimal format and the short- and long-term benefits of chronic obstructive pulmonary disease (COPD)
SM interventions in adults. Therefore, a high-quality overview of reviews was updated to examine their clinical
effectiveness. Sixteen reviews were identified, interventions were broadly classified as education or action
plans, complex interventions with an SM focus, pulmonary rehabilitation (PR), telehealth and outreach nursing.
Systematic review and meta-analysis quality and the risk of bias of underlying primary studies were assessed.
Strong evidence was found that PR is associated with significant improvements in health-related quality of life
(HRQoL). Limited to moderate evidence for complex interventions (SM focus) with limited evidence for
education, action plans, telehealth interventions and outreach nursing for HRQoL was found. There was
strong evidence that education is associated with a significant reduction in COPD-related hospital
admissions, moderate to strong evidence that telehealth interventions and moderate evidence that complex
interventions (SM focus) are associated with reduced health care utilization. These findings from a large body of
evidence suggesting that SM, through education or as a component of PR, confers significant health gains in
people with COPD in terms of HRQoL. SM supported by telehealth confers significant reductions in healthcare
utilization, including hospitalization and emergency department visits.
Keywords
Self-management, self-management interventions, COPD, chronic disease, overview of review, systematic
review
Date received: 11 May 2016; accepted: 1 December 2016
1 Health Technology Assessment, Health Information and Quality Authority, Dublin, Ireland
2 Centre for Primary Care and Public Health, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary
University of London, London, UK
3 RCSI Department of General Practice, Royal College of Surgeons in Ireland, Dublin, Ireland
4 Asthma UK Centre for Applied Research, Allergy and Respiratory Research Group, Usher Institute of Population Health Sciences and
Informatics, University of Edinburgh, Scotland, Edinburgh, UK
Corresponding author:










Creative Commons CC-BY-NC: This article is distributed under the terms of the Creative Commons Attribution-Non
Commercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction
and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages
(https://us.sagepub.com/en-us/nam/open-access-at-sage).
Introduction
The World Health Organization predicts that by 2030
chronic obstructive pulmonary disease (COPD) will
be the third leading cause of death globally.1 There is
no cure currently, but proactive management can
improve health outcomes. In the later stages of the
disease, health service use often increases with fre-
quent hospitalizations.
SM is defined in general as ‘the systematic provi-
sion of education and supportive interventions by
health care staff to increase patients’ skills and con-
fidence in managing their health problems, including
regular assessment of progress and problems, goal
setting, and problem-solving support’.2
SM interventions to enhance SM skills and to
improve self-efficacy are very broad, which may be
due to the lack of an agreed definition until very
recently. In 2012, the UK National Institute for Health
Research commissioned the PRISMS study, an
overview of reviews of SM support interventions,
published in 2014. PRISMS proposed SM support
taxonomy (not specifically for COPD), which
includes four ‘overarching dimensions’ to aid descrip-
tion and characterization – delivery mode; personnel
delivering the support; intervention targeting; and the
intensity, frequency and duration of the intervention.3
A recent agreed definition of COPD SM interventions
by an international expert group states that ‘a COPD
SM intervention is structured but personalized and
often multi-component, with goals of motivating,
engaging and supporting the patients to positively
adapt their health behaviour(s) and develop skills to
better manage their disease’.4 They state that the ulti-
mate goals of SM include optimizing and preserving
physical health; reducing symptoms and functional
impairments in daily life and increasing emotional
well-being, social well-being and quality of life; and
establishing effective alliances with healthcare profes-
sionals, family, friends and community.4 They also state
that iterative interactions with healthcare professionals
focus on identifying needs, eliciting goals, formulating
strategies and re-evaluating these as necessary. An
agreed definition of COPD SM interventions by an
international expert group is an important step forward;
however, the benefits of this agreed definition and pro-
posed taxonomy may not be known for some time until
they are fully and uniformly adopted.
To date, a large volume of literature has been
published on COPD SM interventions.5 However,
uncertainty regarding optimal format and short- and
long-term benefits still exists presenting an obstacle to
informed decision-making about COPD SM provision.
In addition, SM interventions are evolving rapidly, and
it is therefore timely to update the PRISMS overview.
This study aimed to determine the clinical effectiveness
of SM interventions for adults with COPD. The out-
comes of interest are health-related quality of life
(HRQoL), health care utilization and mortality.
Methods
A scoping review identified a large body of clinical
effectiveness literature including multiple systematic
reviews evaluating a range of SM interventions in
chronic diseases. We adopted an ‘overview of reviews’
approach, a term used by the Cochrane Library,
described as an efficient method to systematically
gather evidence and provide broad statements on the
effectiveness of interventions.6 It is particularly useful
for informing health service policy and delivery.7,8 A
high-quality overview of reviews, PRISMS study, was
used as a basis3 and the results were combined to give
an updated overview of the available evidence.
Search strategy and study selection
The systematic overview was conducted in accordance
with the preferred reporting items for systematic
reviews and meta-analyses (PRISMA) guidelines.9 The
search was carried out using PubMed, Embase and the
Cochrane Library with results retrieved from January
2013 to 1 April 2015. January 2013 was selected to
coincide with the practical systematic reviews in self-
management support (PRISMS) search end date (Janu-
ary 1993 to January 2013). Our search was undertaken
as part of a wider study of chronic disease SM interven-
tions where a broader search string was used. Chronic
disease terms including ‘COPD’ terms were combined
with ‘self-management’ and ‘systematic review’ terms
or filters in a sensitive search strategy (Table 1). Citation
lists of included studies and relevant systematic reviews
were scanned. Cochrane reviews included in PRISMS
were checked for updates. Reviews in English were
included.
Participants, Interventions, Comparators,
Outcomes and Study design (PICOS)
Systematic reviews of randomized controlled trials
(RCTs) comparing SM interventions with routine care
for adults (18 years) with COPD were included.
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Any systematic reviews of SM interventions that
helped patients to manage aspects of their COPD
through education, training and support were
included. With the exception of education interven-
tions or action plans, this review did not assess single
component SM (e.g. text message appointment remin-
ders). All formats and delivery methods were consid-
ered (including telehealth, not a specific focus of
PRISMS and are therefore included from 2009
onwards. This is discussed further in the Discussion
section). Pulmonary rehabilitation (PR) was consid-
ered to include SM if it encompassed, for example,
providing information about COPD; building skills
like goal setting, problem solving and decision-mak-
ing.10 The primary outcomes of interest were HRQoL,
health care utilization and mortality.
Data extraction and quality assurance
Preliminary screening of all returned results was per-
formed by a single person to eliminate clearly irrele-
vant studies. Two reviewers independently screened
titles, abstracts and then full texts using the defined
inclusion and exclusion criteria. Disagreements were
resolved by discussion. Data extraction was per-
formed independently by two people, with disagree-
ments resolved by discussion.
Quality assessment of the systematic reviews was
carried out by two people independently using the
Revised Assessment of Multiple Systematic Reviews
(R-AMSTAR) quality appraisal tool (minimum score
¼ 11, maximum ¼ 44).11 Reviews were categorized
as higher quality (31), lower quality (<31) and
lower impact (participants <1000). Participant num-
bers do not affect the quality of the systematic review
process but provide information about the volume of
evidence. We used these to weigh our interpretation
of the evidence per review (Table 2).5,7
Data from the primary RCTs included in the systema-
tic reviews was extracted, where available,6 from all
individual RCTs as this information was not included
in the PRISMS study. The reviews were categorized as
being at high (>50% of included RCTs at high risk of
bias) or low risk of bias (50% at high risk of bias). If a
meta-analysis was undertaken, the methodological
quality was categorized into high, medium and low
quality using Higgins et al.’s quality assessment tool
to facilitate interpretation of findings (Table 2).7
SM interventions were classified into broad inter-
vention types based mainly on the reviews retrieved,
the PRISMS study and taxonomy to facilitate com-
parison. RCT crossover between reviews was
assessed as it could affect interpretation of results. If
there was substantial crossover between two reviews
(>70%), if one study was deemed better quality
(R-AMSTAR score) and was published the same year
or more recently, then the results of the better quality
review were included. Otherwise, results from both
reviews were included.
A narrative approach was used to synthesize the
available evidence (meta-analysis is not appropriate
at overview level due to RCT crossover). To aid inter-
pretation, we broadly categorized the evidence into




1. Chronic disease terms including chronic
obstructive pulmonary disease and
COPD terms.




regulation, self-treat, self-test, self-




instruction, telephone, cell phones, text
messaging, SMS, self-help groups, group
based, social learning theory, behaviour
change theory, behaviour change
program, behaviour change model,
motivational interview, peer led, peer
support, lay led, lay support, health
coach, action plan, care plan, patient
education as topic, Flinders program/
model, chronic care model, expert
patients programme, Stanford model/
program, internet, pulmonary rehab)
3. Systematic review terms (systematic
review, review, meta-analysis, meta-
analysis as topic, meta-review, meta-




1. Chronic disease terms including chronic
obstructive pulmonary disease and
COPD terms.
2. Self-management support intervention
terms as above.
3. Filter by Cochrane reviews, other
reviews, technology assessments.
SM: self-management; SMS: short message service; COPD:
chronic obstructive pulmonary disease.
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‘strong’, ‘moderate’ and ‘limited’ strength of evi-
dence based on the quality of the evidence and the
statistical significance of the results (Table 2).
Results
Study detail
Sixteen systematic reviews were retrieved that
assessed a diverse range of COPD SM interventions
including education and action plans, complex inter-
ventions with a focus on SM, PR and interventions
delivered using telehealth (Figure 1; Table 3). Five
reviews were identified in PRISMS and a further 11 as
part of this study. Publication dates ranged from 2005
to 2015 (systematic reviews) and from 1977 to 2013
(included RCTs). The number of included RCTs per
systematic review ranged from 314 to 6522 and the
number of participants from 36714 to 3941.17 RCT
study locations were typically in Europe or North
America. The 16 reviews included a total of 165 unique
RCTs with approximately 16,500 participants; see
Table 4 for study crossover. Results from the reviews
by Harrison et al.18 and Bentsen et al.16 are not dis-
cussed further due to large study crossover (>70%)
with another higher quality review by Jordan et al.21
and Zwerink et al.,20 respectively (Tables 5 and 6).
Quality appraisal and risk of bias
Systematic review quality, RCT and participant
numbers, meta-analysis quality and the risk of bias
of the underlying RCTs are included in Table 3.
Three reviews were rated lower quality16,18,24
(R-AMSTAR <31) with the remainder rated higher
quality. Six reviews had fewer than 1000 partici-
pants.14–16,23,24,28 The systematic reviews and
meta-analyses are of high quality, but the underpin-
ning RCTs are generally at high risk of bias. Results
from the meta-analyses for the outcomes of HRQoL,
healthcare utilization and mortality are discussed in
the following summary of findings section and are
summarized in Table 5.
Summary of findings
Education and action plans. Four reviews of 33 RCTs
(26 unique RCTs) were identified, all from the
PRISMS review. One Cochrane review (Effing et al.)
assessed education with or without action plans.12
Education focused on improving COPD knowledge
and understanding directed towards, for example,
smoking cessation, improving exercise, inhalation
techniques or coping strategies. A second Cochrane
review assessed action plans not including educa-
tion,14 defined as the use of guidelines outlining self-
initiated interventions such as altering medication or
visiting the hospital. The third review, an update of the
previous Cochrane review assessing action plans but
also included brief patient education.15 The fourth
assessed patient managed disease-specific education
programmes consisting of, for example, COPD infor-
mation, smoking cessation suggestions, inhaler tech-
niques, early recognition of signs requiring medical
interventions and education.13 The author suggests
that these programmes could be an alternative to
time-consuming, expensive PR programmes.
Table 2. Quality assurance of systematic reviews and evidence of effect.a
Quality of systematic reviews
Quality of systematic review (R-AMSTAR) Systematic review sample size Overall value
Lower quality (R-AMSTAR score <31) Smaller sample size (<1000 participants) Low/Low
Lower quality (R-AMSTAR score <31) Larger sample size (1000 participants) Low/High
Higher quality (R-AMSTAR score 31) Smaller sample size (<1000 participants) High/Low
Higher quality (R-AMSTAR score 31) Larger sample size (1000 participants) High/High
Evidence of effect
0 p > 0.05 No evidence of effect
þ/ 0.05  p > 0.01 Some evidence of effect in favour of intervention/control
þþ/  0.01  p > 0.001 Strong evidence of effect in favour of intervention/control
þþþ/   p  0.001 Very strong evidence of effect in favour of intervention/
control
R-AMSTAR: Revised Assessment of Multiple Systematic Reviews.
aTable adapted from PRISMS study.
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All four reviews reported HRQoL outcomes with
evidence rated as limited, two focused mainly on edu-
cation showing a small but significant positive effect
(Table 6).12,13 All four reported on hospitalization
with evidence rated as strong, two mainly focused
on action plans found no statistically significant
impact14,15 and two focused on education showed a
significant reduction.12,13 No reviews reported results
for mortality. The fact that no further studies were
retrieved in our updated search may indicate that it
is clear that education forms an important part of SM
but that further interventions to enhance this may
improve results. This is evident from the review by
Effing et al.,12 which was updated in 2014 by Zwerink
et al.20 They noted that although patient education
is an indispensable component of SM, education
alone is insufficient to achieve the goal of beha-
vioural change and to avoid ambiguity, they
removed the term ‘education’ from the title of the
review and broadened their inclusion criteria (i.e.
no longer just education and action plans). As such,
this review by Zwerink et al. is discussed in the
section on ‘complex SM interventions’. This is in
agreement with a recent international consensus
statement on SM in COPD states that formalized
education is centre stage to SM but while COPD
SM interventions often include education and
action plans, the intervention is considered to be
more than the sum of these two components.4
Complex interventions with a focus on SM. Reviews of
complex interventions with an SM focus are
defined as those that typically included a range
of SM interventions. They may involve multiple
components and/or multiple professionals with
the intervention delivered by a variety of means.
Four reviews of 100 RCTs (77 unique RCTs)
were included all of which were from our
updated search.
One review assessed complex SM interventions as
described earlier; these could use technology or
include education or rehabilitation.17 The second
review assessed integrated disease management inter-
ventions defined as programmes provided by
Search results post 2012:
PubMed (n = 744)
Embase (n = 1174)
Cochrane (n = 548)
Titles for full review:
Included studies (n = 11) 
Irrelevant studies (n = 36):
not effectiveness of SMS (n = 9)
not systematic reviews (n = 2)
study design (n = 2)
abstract/protocol/poster/letter  (n = 9)
duplicate study (n = 4)
intervention (n = 5)
population (n = 4)
outcomes (n = 1)
Irrelevant to COPD group  
based on title and abstract 
(n = 2307)
110 duplicates removed
Identified through review of 
references (n = 1).
Check if Cochrane reviews   
included in PRISMS are 
updated (n = 1)
Figure 1. PRISMA flow diagram of updated search results. Note: PRISMS retrieved a further five studies.



































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































caregivers from at least two different disciplines, with
two different components (e.g., self-management,
exercise, education).19 The third review assessed
interventions with at least two interactions with a
participant and healthcare provider and ideally also
included formulation of goals and provision of feed-
back.20 It also had to include at least two of the
following: smoking cessation, self-recognition and
self-treatment of exacerbations, an exercise compo-
nent, diet advice, medication advice or coping with
breathlessness. Content could be delivered to study
participants verbally, as written material or via
audiovisual media. The fourth review assessed SM
for patients with moderate to severe COPD, which
included an SM component or package delivered to
patients shortly after being discharged from hospital
with a COPD exacerbation.21
Three reviews reported on HRQoL with evidence
rated as limited to moderate,19–21 one review showed
a significant positive effect20 (Table 5). Three reviews
reported on hospitalization with evidence rated as
moderate, two showed a significant reduction.20,21
One out of three reviews reported a significant reduc-
tion in emergency department (ED) visits.17 Three
reviews reported on mortality with none showing a
significant effect.19–21
Pulmonary rehabilitation. Although PR could be consid-
ered a complex intervention with a focus on SM, it is
presented separately as a unique COPD SM interven-
tion. We identified one review of 65 RCTs, a
Cochrane review published in 2015 retrieved in our
updated search.22
PR was defined as exercise training for at least 4
weeks with or without education and/or psychological
support delivered to patients with exercise limitation
attributable to COPD. This review reported on a pri-
mary outcome of HRQoL and a secondary outcome of
exercise testing. Eleven out of 11 outcomes (eight for
HRQoL and three for exercise capacity) showed a
significant positive effect (Supplementary Table
S1). The evidence for HRQoL was rated as strong.
The authors report that large variation in the design
of PR programmes makes it difficult to identify their
optimal format.
Telehealth. Telehealth, telemedicine or telemonitoring
are broad terms with no one universally accepted def-
inition for each. A convention is developing, which
uses ‘telehealth’ for health-based IT-based care, so we
will use this term. Four reviews of 38 RCTs (30
unique RCTs) are included from our updated search.
One review assessed home telemonitoring for
COPD patients where healthcare providers review
patients’ clinical data more regularly and promptly
to detect health deterioration.23 The second review
assessed healthcare at a distance, involving commu-
nication of data between patient and health carer with
feedback regarding COPD management.26 The third
review included nurses monitoring patients from a
telemonitoring centre and documenting their physical
and mental status daily to allow for identification of
Table 4. Study crossover between the included systematic reviews.a
Review (year) A B C D E F G H I J K L M N O P
A Bentsen et al.16 4
B Effing et al.12 2 13
C Tan et al.12 2 4 12
D Turnock et al.14 0 1 1 3
E Wong et al.27 1 4 2 0 9
F Cruz et al.23 0 0 0 0 0 10
G Dickens et al.17 1 5 4 1 4 1 32
H Harrison et al.18 0 0 2 0 1 0 4 7
I Kamei et al.24 0 0 0 0 0 2 0 0 7
J Kruis et al.19 1 4 2 0 4 1 1 1 0 26
K Lundell et al.25 1 1 2 0 1 0 1 1 0 1 9
L Zwerink et al.20 3 6 5 0 2 1 7 1 0 6 2 29
M McLean et al.26 1 1 2 0 1 0 3 3 2 1 3 3 10
N Walters et al.15 0 2 1 3 0 0 3 1 0 1 0 0 0 5
O Jordan et al.21 0 0 2 0 2 0 4 5 0 1 1 1 2 0 10
P McCarthy et al.22 0 3 0 0 1 0 3 0 0 12 0 2 0 0 1 65
aPRISMS study is based on a search from 1993 to January 2013. This search was updated to April 2015.





















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































early exacerbations and to provide education and
mentoring from a distance.24 The fourth review
assessed home-based solutions to making PR more
accessible.28
Two of four included reviews reported HRQoL
outcomes with evidence rated as limited. One
review showed a positive effect for home telemo-
nitoring23 (Table 6). Three of four reviews reported
on hospitalization, with evidence rated as moderate
to strong, all three showed a significant reduc-
tion23,24,26 with healthcare at a distance being the
most significant.26 Three reviews reported on ED
visits with two showing a significant positive
effect.24,26 Two reviews reported on mortality, nei-
ther showed a significant effect.23,24
Outreach nursing. One review did not fit into the afore-
mentioned categories and is more about the personnel
delivering the support which was retrieved by
PRISMS. It assessed an outreach nursing programme
defined as home visits from a respiratory nurse or
similar respiratory health worker to help people use
their treatments well, provide education about coping
strategies and disease monitoring.27 A small but
significant improvement in HRQoL and no significant
reductions in hospitalizations were reported based on
evidence rated as limited.
Discussion
Summary of main findings
Reviews reporting on HRQoL were mainly positive
with 6 out of 11 showing improvements. The stron-
gest evidence was retrieved for PR, which reported
significant improvements, followed by complex inter-
ventions with an SM focus based on evidence rated as
limited to moderate. However, PR contains many
components and it was not clear which components
led to this positive result. Reviews that reported
results for healthcare utilization were also mainly pos-
itive with seven out of eight reviews reporting posi-
tive results for hospitalization and three out of five
reporting improvements for ED visits. The strongest
evidence was retrieved for education followed by
moderate to strong evidence for telehealth interven-
tions and moderate evidence for complex interven-
tions with an SM focus. There is no evidence that
SM interventions have any effect on mortality.














13; 2239 (Effing) High/High High/High þ Limited þþ NR Strong
12; 2103 (Tan) High/High High/High þ þþþ NR
3; 367 (Turnock) High/Low High/High 0 NR NR NA
5; 574 (Walters) High/Low High/High 0 NR NR
Complex interventions with an SM focus
32; 3941 (Dickens) High/High High/Med. NR NA NR þþþ Moderate
26; 2997(Kruis) High/High High/High 0 Limited/
moderate
0 0
29; 3688 (Zwerink) High/High High/High þþþ þþþ NR
10; 1502 (Jordan) High/High High/High 0 þþ Not
combined
Pulmonary rehabilitation
65; 3822 (McCarthy) High/High High/High þþþ Strong NR NR NA
Telehealth
10; 587 (Cruz) High/Low High/High þ Limited þ 0 Moderate/strong
9; 550 (Kamei) Low/Low Low/Med. NR þc þþþ
10; 1004 (McLean) High/High High/High 0 þþþ þþ
Outreach nursing programme
9; 1498 (Wong) High/High High/High þ Limited 0 NR Limited
ED: emergency department; NR: not reported; NA: not applicable; Med.: medium; SM: self-management; COPD: chronic obstructive
pulmonary disease
aSummary of systematic review quality based on R-AMSTAR score and number of participants, see Table 6.
bSummary of the quality of the primary studies based on the risk of bias and meta-analysis quality, see Table 6.
cResult for all COPD patients included, þþ for patients with severe and very severe COPD.
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Interpretation in relation to other literature
This overview was an update of an existing high-
quality systematic overview (PRISMS). The PRISMS
study included 14 long-term conditions, paediatric as
well as adult populations, conducted a review of qua-
litative data and an implementation review. Specifi-
cally, PRISMS did not include telehealth-based
interventions as they deemed them to be about the
mode of delivery rather than the content of what was
delivered. Telehealth is constantly evolving to incor-
porate new advancements and respond and adapt to
changing health needs. As such, telehealth interven-
tions were included in our updated review. While it
was recognized that given the rate of technological
advance, older telehealth reviews might be out of
date, we were concerned that by simply updating the
PRISMS study we would potentially miss out on pre-
2013 reviews on this topic. As previously noted, our
search was undertaken as part of a wider study that
included reviews of SM interventions for other
chronic diseases, a start date of 2009 and a wider
search string. One additional high-quality COPD tele-
health Cochrane review was identified and included
to reduce the impact of this limitation. Overall,
reviews retrieved, which assessed telehealth interven-
tions, varied widely and in some cases only formed
part of a more complex intervention making it diffi-
cult to draw conclusions.
Based on two reviews, PRISMS reported that edu-
cation reduces hospitalization in COPD patients. We
agree with this finding as we did not find any addi-
tional evidence for this intervention. The very fact
that there are no further reviews of education may
indicate that it is clear that education forms an impor-
tant part of SM but that further interventions to
enhance this may improve results. Effing et al.’s Inter-
national consensus document states that formalized
education is centre stage but while COPD SM inter-
ventions often include education and action plans, the
intervention is considered to be more than the sum of
these two components.4 We also retrieved additional
reviews providing moderate to strong and moderate
evidence of a reduction in healthcare utilization (hos-
pitalization or ED visits) for telehealth interventions
and complex interventions with an SM focus, respec-
tively. PRISMS reported that consistent and less clini-
cally significant effects were found for education in
terms of HRQoL improvements across reviews. We
found one additional review that did not alter this
finding. However, we found strong evidence of
significant improvements in HRQoL for PR. We also
found limited to moderate evidence of improvements
in HRQoL for complex interventions with an SM
focus and limited evidence for telehealth interven-
tions and outreach nursing programmes.
As with all overviews of reviews and systematic
reviews, they are conducted for a specific point in
time for which we can state where the evidence is
at. There may have been reviews and RCTs published
after this point in time, for example, Jonkman et al.
published an individual patient data meta-analysis in
2016 (outside of our search dates), which aimed to
identify which characteristics of COPD SM interven-
tions are most effective and included 14 RCTs, 11 of
which are included in this overview of reviews.29 The
RCTs varied by intervention type (group sessions,
individual sessions, exercise sessions, etc.) and dura-
tion. With respect to duration, some interventions
included sessions over a longer period of time or
included follow-up calls and were individual sessions
on 1 day. Duration ranged from 1 day to (n ¼ 1) to
24 months (n ¼ 1) with an average duration of
approximately 1 week. After adjusting for programme
characteristics, they reported that longer duration SM
interventions led to a reduction on all-cause hospita-
lizations in COPD patients. However, they didn’t spe-
cify if this should be in the form of follow-up calls or
more sessions and they were unable to determine what
the minimum required duration should be.
Future research and implications for decision
makers
The clinical effectiveness of COPD SM interventions
provides a complex picture. RCTs typically had small
sample sizes and a short-term follow-up, limiting the
applicability and validity of findings and potentially
failing to capture long-term benefits. Although SM
interventions are generally inexpensive on a per
patient basis, the budget impact of these could be
substantial due to large eligible patients’ numbers. It
is important that the implementation and delivery of
the interventions are subject to routine and ongoing
evaluation. This would help ensure that they are deli-
vering benefits to patients and allow the intervention
content and format to be refined.
Almost all individuals eligible for COPD SM
interventions will have more than one chronic disease
that may also be suitable for SM.30 In these cases,
consideration should be given to whether one
10 Chronic Respiratory Disease
disease-specific intervention is best and whether
exposure to more interventions is overly burdensome.
As such, implementation would require an evidence-
based approach that acknowledges multimorbidity
and considers how the main diseases interact.
Strengths and limitations
Overviews of reviews are gaining in popularity, an
advantage being that they efficiently and systemati-
cally retrieve and summarize results of multiple sys-
tematic reviews into one report. A disadvantage is that
they may not reflect the most recent literature as
recent RCTs must first be captured in a systematic
review to be included. However, given typically small
sample sizes, it may not be appropriate to draw con-
clusions on the effect of an intervention based on a
single or a number of small RCTs. Therefore, it is
unlikely that more recent RCTs not captured in this
overview of reviews would be sufficient to substan-
tially alter recommendations informing major policy
decisions. In addition, some reviews may include
older RCTs with broader inclusion criteria which may
distort results. We included two older Cochrane
reviews but also included their updated versions
which should minimize distortion of results.
Difficulties arise in distilling large bodies of liter-
ature into clear and useful findings hindered by the
wide range of SM definitions in the literature; large
range of SM interventions available; varying delivery
formats and that intervention, for example PR, con-
tent can vary from programme to programme. Com-
bining a large body of literature that assesses such a
range of interventions is challenging. We broadly
categorized our results into common SM interven-
tions retrieved in our search to aid presentation of
results. However, this broad categorization may be a
limitation as there is still crossover between cate-
gories. To aid interpretation, we categorized evidence
into ‘strong’, ‘moderate’ and ‘limited’ based on the
quality of the evidence and the statistical significance
of results (Table 2). These criteria are broadly based
on the GRADE requirements,31 full GRADE criteria
could not be adhered to as it is for grading primary
RCTs included in systematic reviews. Our approach
helps distil the information, but should not be
reviewed in isolation from the detailed results to
avoid misinterpretation. Issues may also arise con-
ducting an overview of reviews as the reviewer is one
step away from the primary evidence. We found that
the systematic reviews and meta-analyses included
were of high quality, but the underpinning RCTs were
generally at high risk of bias. By assessing both the
quality of the systematic review and meta-analysis
and the risk of bias of the primary studies, we reduced
the impact of this limitation. Finally, the potential for
double counting of primary evidence or included
RCTs was dealt with by assessing RCT crossover to
ensure positive or negative results were not overem-
phasized if there was large overlap.
The Cochrane handbook provides valuable infor-
mation on the overarching methods for overviews of
reviews.32 However, more detailed guidance is
required. A recent protocol published in 2016 aims
to produce an evidence map of studies evaluating
methods for conducting, interpreting and reporting
overview of reviews, which should help standardize
and optimize approaches.33
Gaps in the evidence
There is a lot of evidence for chronic disease SM. A
factor that may contribute to inconsistent evidence is
the lack of a clear SM definition across both primary
studies and systematic reviews, which has changed
over time. The inclusion and exclusion criteria of
identified systematic reviews were often based on
very broad descriptions of interventions, adding to the
heterogeneity of data and may have introduced some
distortion in the results. A consensus on the definition
of SM in COPD by Effing et al. in 20164 is an impor-
tant step forward and should ultimately help with
future reviews of effectiveness of SM interventions
in COPD by facilitating the identification of a more
narrowly defined, but possibly less heterogeneous
evidence-base; the proposed PRISMS taxonomy may
help with this also.3 However, this agreed definition
or taxonomy will still need to be fully and uniformly
adopted and used for a time before its value can be
realized. Any future reviews can be compared to this
overview of reviews to determine whether the intro-
duction of an agreed definition of COPD SM
improves the review of effectiveness of these inter-
ventions providing recommendations for consensus in
other chronic diseases.
Conclusion
These findings from a large body of evidence suggest-
ing that SM, through education or potentially as a
component of PR, confers significant health gains in
people with COPD in terms of HRQoL. SM supported
by telehealth confers significant reductions in health
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care utilization, including hospitalization and
ED visits.
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